丽珠集团 (000513)

LIVZON PHARMACEUTICAL GROUP INC.

ASZ

Tags

DeepSeekCSI Share Buyback IndexWeight Loss DrugsInnovative DrugsPharmaceutical ManufacturingContains H-SharesGuoxin Value IndexGuozheng Value IndexGene ConceptPet EconomySmall Cap ValueSustainable GrowthBiological VaccinesGuangdong-Hong Kong-Macao Greater Bay AreaHigh-Performing StocksFree Cash FlowMargin Trading and Securities LendingAssisted ReproductionNorthbound Connect Heavy PositionsSZSE 300 IndexSZSE Value IndexSZSE Dividend Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 90410.04
  • Circulating A-Shares(W): 58414.63
  • Earnings Per Share(RMB): 1.9600
  • Net Assets Per Share(RMB): 15.4439
  • Operating Revenue(W RMB): 911591.43
  • Total Profit(W RMB): 249654.50
  • Net Profit Attributable to Parent(W RMB): 175410.03
  • Net Profit Growth Rate(%): 4.86
  • Weighted Return on Equity(%): 12.4900
  • Operating Cash Flow Per Share(RMB): 2.7930
  • Undistributed Profit Per Share(RMB): 13.8550
  • Capital Reserve Per Share(RMB): 0.3305

2. Main Business

The main business covers:

  • Research, production, and sales of pharmaceutical products

3. Company Basic Information

  • Company Name: Livzon Pharmaceutical Group Inc.
  • Listing Date: 1993-10-28
  • Industry: Pharmaceutical Manufacturing
  • Address: Headquarters Building, No. 38 Chuangye North Road, Jinwan District, Zhuhai City, Guangdong Province
  • Website: www.livzon.com.cn
  • Company Profile: The company's predecessor was Livzon Pharmaceutical (Group) Co., Ltd. It began a shareholding system restructuring in March 1992, converting the original company's net assets into 48.64 million shares for domestic promoters and 15.20 million shares for overseas promoters. After two public offerings in June and September of the following year, the total number of shares reached 162.88 million when the A-shares were listed on October 28, 1993. The 28.346 million employee shares were listed for trading on September 29, 1994.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Joincare Pharmaceutical Group Industry Co., Ltd. General Legal Person 22137.68 37.90
2 Hong Kong Securities Clearing Company Ltd. Northbound Funds 1886.26 3.23
3 Shenzhen Haibin Pharmaceutical Co., Ltd. General Legal Person 1683.08 2.88
4 Guotai Asset Management Co., Ltd. - Social Security Fund 1102 Portfolio Social Security Fund 588.17 1.01
5 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 528.53 0.90
6 China Life Insurance Company Limited - Traditional - General Insurance Product - 005L-CT001 Hu General Legal Person 479.35 0.82
7 China Europe Healthcare Hybrid Securities Investment Fund Class A Fund 362.68 0.62
8 Yinhua CSI Innovative Pharmaceutical Industry Exchange Traded Open-End Index Securities Investment Fund Fund 353.42 0.61
9 Guotai Great Health Equity Securities Investment Fund Class A Fund 48.62 0.08
10 Red Soil Innovation Enhanced Return Bond Securities Investment Fund Class A Fund 42.68 0.07

5. Concept Sectors

  • H-Share
  • Biological Vaccine
  • Gene Concept
  • Guangdong-Hong Kong-Macao Greater Bay Area
  • Assisted Reproduction
  • Innovative Drugs
  • Weight Loss Drugs
  • Pet Economy
  • DeepSeek
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • Sustained Growth
  • Heavily Held by Northbound Funds
  • Free Cash Flow
  • SZSE Value
  • Small Cap Value
  • SZSE 300
  • SZSE Dividend
  • CNI Value
  • Guoxin Value
  • CSI Buyback

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information